CME Group Inc. (NASDAQ:CME) saw an upside of 0.74% to close Tuesday at $202.81 after adding $1.49 on the day. The 5-day average trading volume is 1,117,780 shares of the company’s common stock. It has gained $204.37 in the past week. An average of 1,385,450 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 1,342,474.
CME’s 1-month performance is 7.18% or $13.60 on its low of $185.79 reached on 09/21/21. The company’s shares have touched a 52-week low of $144.85 and high of $221.82, with the stock’s rally to the 52-week high happening on 06/01/21. YTD, CME has achieved 11.40% or $20.76. However, the current price is down -8.57%% from the 52-week high price.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
On Sep 13, 30 days have gone by since the last insider trading activity for CME Group Inc. (CME). GEPSMAN MARTIN J (Director) most recently sold 1,000 shares at $188.53 per share on Sep 13. This transaction cost the insider $188,535. Director, GEPSMAN MARTIN J, sold 1,000 shares at a price of $194.25 on Sep 07. Then, on Aug 30, Director GEPSMAN MARTIN J sold 1,000 shares at a price of $201.00 per share. This transaction amounted to $201,003.
The company’s PE ratio for the last five years has touched a high of 43.57 and a low of 12.13. CME stock has a beta of 0.43. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 15.84 while the price-to-book (PB) in the most recent quarter is 2.71.
CME Group Inc. pays an annual dividend of $3.60 per share. Its dividend yield is 1.78% and the payout ratio is 65.30%. CME’s most recent quarterly dividend payment was made on Sep. 27, when it paid $0.90 a share compared with prior rate of $0.90, down 0.0% from last year’s. The company has boosted its dividend for the last 8 consecutive years with the latest dividend decrease of $1.60 reported on Thursday February 4 2021. Measured over the last 3 years, the Dividend has been growing by -3.91% yearly.
It is projected that CME Group Inc.’s next ex-dividend date will be on 9-Dec. CME is expected to distribute $0.90 as its next dividend.
CME Group Inc.’s quick ratio for the period ended June 29 was 1.00, with the current ratio over the same period at 1.00 meaning that CME stock is able to fulfill its debt obligations. As well, the company’s long term debt to equity for the quarter ending June 29 was 0.13, while the total debt to equity was 0.13 while for the period ending June 29; CME Group Inc.’s operating margin was 52.90%. The firm’s gross profit as reported stood at $2.25 billion against revenue of $4.88 billion.
For the quarterly period ending June 29 this year, Net income and sales went down compared to those figures reported in the previous quarter. Analysts expected CME to announce $1.61 per share in earnings in its latest quarter, but it posted $1.64, representing a 1.90% surprise. EBITDA for the quarter stood at more than $771.2 million. CME stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 151.91 billion, with total debt at $4.06 billion. Shareholders hold equity totaling $359.14 million
Let’s look briefly at CME Group Inc. (CME) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 12 October was 68.37% to suggest the stock is trending Neutral, with historical volatility in this time period at 17.57%.
The stock’s 5-day moving average is $201.30, reflecting a +2.26% or $4.49 change from its current price. CME is currently trading +7.39% above its 20-day SMA, -6.11% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 and SMA200 by -4.11% and +13.63% respectively.
Stochastic %K and %D was 89.14% and 91.12% and the average true range (ATR) pointed at 3.86. The RSI (14) points at 62.19%, while the 14-day stochastic is at 89.02% with the period’s ATR at 3.78. The stock’s 9-day MACD Oscillator is pointing at 3.05 and 3.78 on the 14-day charts.
In the most recent analyst report for CME Group Inc. (NASDAQ: CME), Atlantic Equities upgraded it to an Overweight rating. They previously had a Neutral rating on the stock. Analysts offering their rating for CME stock have a consensus rating for the stock as Hold. Currently, 1 brokerage advisors rate CME as a “sell,”, while 12 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 1 rates the stock as overweight while 5 have offered a “buy” rating.
What is CME’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $190.00 and a high of $250.00, with their median price target at $218.50. Looking at these predictions, the average price target given by analysts is for CME Group Inc. (CME) stock is $218.43.